Back to Research Hub
ACADIA Pharmaceuticals Inc.
ACAD
$21.84+0.14 (+0.65%)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.
StreetsValue research for ACADIA Pharmaceuticals Inc. (ACAD)
Members get the full report for ACADIA Pharmaceuticals Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.